Big Pharma

Big Pharma is a factory-builder and management sim wrapped in a mordantly funny premise: you run a pharmaceutical company, and keeping people just sick enough to need your drugs is, mechanically speaking, a valid strategy. Twice Circled released this back in 2015, and the core loop still holds up for a specific kind of player. You source raw ingredients, chain together machines on a grid to refine their active compounds, strip out side effects, and push finished drugs to market at the highest possible price. Every production line is a spatial puzzle. Machines have fixed input and output slots, so routing belts around a cramped factory floor without creating dead ends requires genuine planning. That planning is the game. The depth is real but narrow. Early decisions about which diseases to target, which ingredients to research, and how aggressively to price create meaningful branching paths through a campaign. The tech tree is dense enough that you will not unlock everything in a single run, which gives replays a reason to exist. Difficulty scaling across the scenario maps works well enough that veterans can push into the harder settings where ingredient costs bite hard and competitors undercut you fast. The AI competitors are not spectacular tacticians, but they apply consistent market pressure and will absolutely steal a niche if you ignore them. For newcomers, the tutorial does a reasonable job walking through the basics of machine chaining and compound catalysts without overwhelming you. The concepts build logically: learn to refine a simple compound, then learn to split production lines, then wrestle with the economics of research investment versus immediate production. A first campaign on standard difficulty is genuinely accessible. Where the game respects beginners is in letting you pause, rearrange, and think. Nothing here is real-time twitchy. That said, the UI starts to creak under the weight of a large, mature factory. Finding a specific machine buried under overlapping belts becomes a chore, and the information layers for tracking which drugs are profitable could be clearer. The mod ecosystem is modest but functional. Steam Workshop support exists, and the community has added new ingredients, scenarios, and quality-of-life tweaks that address some of the UI clutter. It is not a Paradox-scale modding community, but the base game's XML-driven data is approachable enough that patient players have produced worthwhile content. The 77 percent positive Steam rating with a Mixed label reflects a real split: factory-builder fans tend to enjoy it, while players expecting a deeper business sim or a narrative layer come away underwhelmed. There is no personnel management, no PR crisis system, no narrative campaigns beyond scenario flavour text. It is lean and focused, which is either a virtue or a flaw depending on what you came for. Bottom line: if you like spatial optimization puzzles and can stay engaged with production-line thinking for 20 to 30 hours, Big Pharma delivers a tight, distinctive experience. If you want the political and social satire its premise implies to run deeper than a loading-screen joke, you will be disappointed fast. Diego, Scout Team